Solu-medrol and Hydropneumothorax - a phase IV clinical study of FDA data

Summary:

Hydropneumothorax is reported as a side effect among people who take Solu-medrol (methylprednisolone sodium succinate), especially for people who are female, 50-59 old, also take Prilosec, and have Bone density abnormal.

The phase IV clinical study analyzes which people have Hydropneumothorax when taking Solu-medrol. It is created by eHealthMe based on reports of 39,265 people who have side effects when taking Solu-medrol from the FDA, and is updated regularly.

What is Solu-medrol?

Solu-medrol has active ingredients of methylprednisolone sodium succinate. It is often used in multiple sclerosis. eHealthMe is studying from 39,410 Solu-medrol users. Check the latest studies of Solu-medrol.

What is Hydropneumothorax?

Hydropneumothorax (presence of both air and fluid in the pleural space (lungs)) is found to be associated with 117 drugs and 127 conditions by eHealthMe. Check the latest studies of Hydropneumothorax.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

39,265 people reported to have side effects when taking Solu-medrol.
Among them, 16 people (0.04%) have Hydropneumothorax.

Could Solu-medrol cause Hydropneumothorax?

Among these 16 people:

What is the gender of people who have Hydropneumothorax when taking Solu-medrol? *

female: 87.5 %
male: 12.5 %

What is the age of people who have Hydropneumothorax when taking Solu-medrol? *

What are other drugs people take besides Solu-medrol? *

What are other side effects people have besides Hydropneumothorax? *

Atelectasis (partial or complete collapse of the lung): 16 people, 100.00%
Fall: 16 people, 100.00%
Gait Disturbance: 16 people, 100.00%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 16 people, 100.00%
Injury: 16 people, 100.00%
Depression: 16 people, 100.00%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 15 people, 93.75%
Osteoradionecrosis (irradiation of bones causes damage to osteocytes and impairs the blood supply): 15 people, 93.75%
Foot Fracture: 15 people, 93.75%
Gastritis (inflammation of stomach): 15 people, 93.75%

What are the existing conditions these people have? *

Bone Density Abnormal: 14 people, 87.50%
Osteoporosis (bones weak and more likely to break): 4 people, 25.00%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 6.25%
Heart Rate Increased: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Solu-medrol and have Hydropneumothorax?

- Check whether Hydropneumothorax is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Solu-medrol:

Solu-medrol (39,410 reports)

Hydropneumothorax treatments and more:

Hydropneumothorax (227 reports)

How severe was Hydropneumothorax and when was it recovered:

Hydropneumothorax in Solu-medrol

Expand to all the drugs that have ingredients of methylprednisolone sodium succinate:

Hydropneumothorax and drugs with ingredients of methylprednisolone sodium succinate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Solu-medrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hydropneumothorax:

Hydropneumothorax (117 drugs)

Browse all the conditions that are associated with Hydropneumothorax:

Hydropneumothorax (127 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on methylprednisolone sodium succinate (the active ingredients of Solu-medrol) and Solu-medrol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.